Bristol-Myers Squibb Co’s filing revealed that its EVP, Corporate Affairs Short Bartie Wendy unloaded Company’s shares for reported $16719.0 on Aug 02 ’25. In the deal valued at $44.23 per share,378 shares were sold. As a result of this transaction, Short Bartie Wendy now holds 5,066 shares worth roughly $0.23 million.
Then, Hickey Benjamin sold 97 shares, generating $3,702 in total proceeds. Upon selling the shares at $38.01, the President, RayzeBio Org. now owns 0 shares.
Before that, Hirawat Samit bought 4,250 shares. Bristol-Myers Squibb Co shares valued at $202,215 were divested by the EVP,Chief Med.Offr.,Drug Dev. at a price of $47.58 per share. As a result of the transaction, Hirawat Samit now holds 83,513 shares, worth roughly $3.84 million.
Daiwa Securities downgraded its Bristol-Myers Squibb Co [BMY] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. Cantor Fitzgerald began covering BMY with “Neutral” recommendation on April 22, 2025. Jefferies revised its rating on December 16, 2024. It rated BMY as “a Buy” which previously was an “a Hold”.
Price Performance Review of BMY
On Friday, Bristol-Myers Squibb Co [NYSE:BMY] saw its stock jump 1.30% to $45.95. Over the last five days, the stock has gained 3.89%. Bristol-Myers Squibb Co shares have fallen nearly -2.87% since the year began. Nevertheless, the stocks have fallen -18.76% over the past one year.
How much short interest is there in Bristol-Myers Squibb Co?
A steep rise in short interest was recorded in Bristol-Myers Squibb Co stocks on 2025-07-15, growing by 4.77 million shares to a total of 38.38 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 33.61 million shares. There was a rise of 12.43%, which implies that there is a positive sentiment for the stock.
